Company Overview of Cobalis Corp.
Cobalis Corp., a development stage company, engages in the development and commercialization of pharmaceutical products for allergic diseases. Its product includes PreHistin, a phase III clinical trial product candidate for the treatment of atopic allergic diseases, including seasonal and year-round allergies, migraine, dermatitis, food allergies, and asthma. The company was incorporated in 2000 and is based in Irvine, California. On November 19, 2007, the involuntary petition of Cobalis Corp for liquidation under Chapter 7 bankruptcy was converted to voluntary Chapter 11 reorganization. The involuntary petition was filed on August 1, 2007.
2030 Main Street
Irvine, CA 92614
Founded in 2000
Key Executives for Cobalis Corp.
Cobalis Corp. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Wynden Pharmaceuticals LLC||United States|
|Eye-Pharma, LLC||United States|
|Procare Rx, Inc.||United States|
|PPD Vaccines and Biologics, LLC||United States|
|Spring Bank Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cobalis Corp., please visit www.cobalis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.